Lexpos News

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (05/03/2025) announced the following final list of price concessions for February 2025: Drug Pack size Price concession Desmopressin 240microgram sublingual tablets sugar free 30 £36.32 Paracetamol 500mg effervescent [...]

The post February 2025 Price Concessions Final Update appeared first on Community Pharmacy England.

NHS England and Community Pharmacy England continue to recommend that pharmacy team members with NHS Smartcards take the following actions to support ongoing use of their smartcards. If your smartcard or role on your smartcard was set up a long time ago, there may be an action for you to update it to keep it [...]

The post Reminder: NHS Smartcard action required: checking contact info, self unlock and expiry appeared first on Community Pharmacy England.

Drug alert number: EL (25)A/10 Date issued: 4 March 2025 Aspar Pharmaceuticals Limited have informed the MHRA of an error related to a batch of Boots Paracetamol 500 mg tablets (16s). The foil blister inside the carton incorrectly states ‘Aspirin 300 mg Dispersible Tablets’. The tablets are confirmed to be Paracetamol 500 mg tablets. Boots [...]

The post MHRA Class 2 Medicines recall: Paracetamol 500 mg tablets (16s) (Boots) appeared first on Community Pharmacy England.

Drug alert number: EL(25)A/09 Date issued: 4 March 2025 Sun Pharmaceutical Industries Europe B.V. is recalling those product batches listed in this notification as a precautionary measure due to out of specification results reported for the Particulate Matter Test (PMT) during stability testing. Medicine Details Pemetrexed SUN 10 mg/ml solution for infusion (Infusion bag) (PL: [...]

The post MHRA Class 2 Medicines recall: Pemetrexed 1000mg/100ml (10mg/ml) & 800mg/ml (8mg/ml) Infusion bag (Sun Pharmaceutical Industries Europe B.V) appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection Drug Alert Number: EL(25)A/08 Date issued: 03 March 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection DMRC reference [...]

The post MHRA Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection appeared first on Community Pharmacy England.